Gaucher's disease is an autosomal recessive inherited disorder, charac
terized by genetic deficiency of lysosomial glucocerebrosidase. Its su
bstrate (glycosylceramide) subsequently accumulates in cells of monocy
te/macrophage origin, resulting in enlargement of the spleen and liver
, skeletal lesions, and, in the mast severe phenotypes, in neurologica
l disorders. Thirty-six mutations have been at present documented in t
he gene encoding for the glucocerebrosidase, but four of them them (N3
70S, L444P, 84GG and IVS2+1) are really frequent, particularly in ashk
enaze population. Gaucher's disease is diagnosed by the presence of Ga
ucher cells, especially in bone marrow aspirate, and by assessing the
glucocerebrosidase activity. The prognosis has been considerably impro
ved by enzyme replacement therapy.